here is something I thought you would like. Medical

New Post Public Reply Private Reply Replies (1) Message Board
john1234 BURN.NOTICE88 #5377
here is something I thought you would like.

Medical Marijuana and The United States… A Tenth Amendment Joke

How intuitive were our forefathers? Was the Constitution a living document? Or was it something that was set in stone, meant to be followed throughout the ages, regardless of how mankind evolved with technologies, pharmaceuticals, and guns? With so many judges on the Supreme Court claiming to be strict constitutionalists, one can’t help but wonder how we haven’t stumbled across the 10th amendment question, regarding marijuana prohibition. Eventually someone’s going to have to address the “Elephant in the room.” How is it? The current federal government feels that they have been empowered, under the Constitution to prohibit different states and their local municipalities from legalizing marijuana? As we now understand it, “Federal law” prohibits the possession of pot. Yet… if a simple federal law can ban marijuana – Why was it that alcohol Prohibition required a constitutional amendment?


Quote:
The states remained suspicious that the new federal government would encroach on their powers. They demanded and got ten amendments to the Constitution that specifically banned Congress from passing laws on matters that were understood to be within state control. The Tenth Amendment flatly declared, “The powers not delegated to the United States by the Constitution, nor prohibited by it to the states, are reserved to the states respectively, or to the people.

[
When one looks at the collective American history of cannabis, hemp and the “redheaded stepchild,” the marijuana plant; we see that it was legal to both “cultivate marijuana” and “possess” for consumptions under both federal law and state laws. As the seeds of marijuana medicine began to spread throughout the United States, by 1840 marijuana’s known pharmacological potential had begun to be recognized by many noted U.S. doctors. In the United States history… there was a brief moment of “shining clarity” from 1850 – 1941 when cannabis had a starring role within the United States Pharmacopeia of available medicines for the pains, aches, and other medicinal needs of the late 1900s.

However that was short-lived and came to a painful end thanks to William Randolph Hearst and his band of thugs. Hell bent on a “rape and pillage” the earth mentality. Hemp was out. Tobacco, cotton, and plastics were in. By the end of 1936 the party was all but over. The “fat lady” had sung… and the tune was a “Death March” of ignorance.

The hits were hard and fast. All 48 states enacted laws outlawing and prohibiting the plant that had saved this nation’s ass, from its birth and through both world wars. With the onset of new pharmacological discoveries, marijuana was for the first time – was relegated to the sleepy, dark shadows of prohibition and called a narcotic. While the focus turned to a new class of drug’s – Aspirin and Opiates; Opium was the new hero of the day… it’s newly derived high from morphine helped kick marijuana to the proverbial prohibition curb. No longer needed in this modern world for the management of human pain. No. There is no limit to the art of deception, the Fed’s and Big Pharma will stop at nothing, to jail your youth and pick your pockets of any loose change not already allocated to one of their corrupt corporate pals.

reference source
http://marijuana.com/news/2012/07/medical-mar...ment-joke/

Rightsmile Inc. (RIGH) Stock Research Links

RIGH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RealNex Navigator Upgrades Unveil Vast CRE Capabilities

Updated Category News Views 1

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 2

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 4

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 0

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 4

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 0

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 0

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 45

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading
ection End -->

Top 5 Most Recently Viewed Articles

Revolutionizing Views: Space Needle's New Otis Elevators

Updated Category News Views 169

Space Needle Unveils Modern Otis Double-Deck Elevators In a significant upgrade to enhance visitor experiences, the Space Needle has launched its first Otis double-deck glass elevator. This innovative lift is part of a larger project to modernize three elevators at the iconic structure, providing a unique ride with stunning panoramic views. A First Look at the Innovative...

Continue Reading
Key Insights from the Upcoming Press Conference on Assault Case

Updated Category News Views 199

Important Press Conference on Recent Assault Case Attorneys from Matheson & Associates, PLLC are set to hold an impactful press conference aimed at shedding light on a serious incident involving truck drivers engaged in Hurricane Helene cleanup efforts. This incident has raised significant concerns about safety and racial tensions. Understanding the Incident On an...

Continue Reading
Couche-Tard Clarifies Intentions Amid Seven & i Interest

Updated Category News Views 255

Alimentation Couche-Tard Addresses Acquisition Negotiations In recent discussions reported by Japanese media, Alimentation Couche-Tard has made it clear that they are not pursuing a hostile takeover of Seven & i Holdings. Chairman Alain Bouchard emphasized that their strategy focuses on securing a collaborative acquisition approach, rather than a forced or antagonistic...

Continue Reading
Legend Biotech Maintains Strong Outlook Despite Sales Fluctuations

Updated Category News Views 97

Overview of Legend Biotech's Market Performance Legend Biotech Corp. (NASDAQ: LEGN) has been the focus of investor attention lately, with analysts maintaining a Buy rating and a price target of $91. This confidence stems from recent sales data for CARVYKTI, a treatment for multiple myeloma, which saw impressive performance in its latest quarter. CARVYKTI Sales Surpass...

Continue Reading
Transforming Alzheimer's Diagnostics: New Guidelines Unveiled

Updated Category News Views 111

New Era in Alzheimer's Disease Diagnosis In a significant advancement for the diagnosis of Alzheimer’s disease and related cognitive impairments, a comprehensive set of clinical practice guidelines has been introduced, marking a pivotal moment for both primary and specialty care. This newly established guideline serves as a beacon for healthcare providers, ensuring they...

Continue Reading